BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

SILREAL at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

SILREAL takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on China's rise in clinical development and what it means for deals. One sets out what Western buyers must resolve about China-origin evidence and policy risk before they sign.

OrganizationBIO-Europe 2026 Attendance
Consulting, legal & services
Consultancy advising pharma, medtech and digital health companies on China-Europe policy, regulation, market access and expansion.
Talk
Tue Nov 10
09:30–09:45
Before the Deal: What Western Buyers Must Resolve About China-Origin Evidence and Policy Risk
What Western buyers should check before buying rights to a China-developed drug, from whether its trial data satisfy European regulators to political risk.
Panel
Tue Nov 10
09:45–10:45
China’s Clinical Revolution: From Regional Player to Global Innovation Engine
Why global drug companies license more drugs from Chinese biotechs, and how China's fast trials and changing rules can speed worldwide development.
with Tigermed, MSQ Ventures, Alkeus Pharmaceuticals

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at SILREAL

Tell us what you sell and we’ll find the people at SILREAL most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction